Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : ADVR:THE NEW COMPANY...WITH A NEW LIFE...AND A NEW MISSION -- Ignore unavailable to you. Want to Upgrade?

To: Kingfisher who wrote (3982)	5/15/1999 9:57:00 PM
From: Bill Evans	Read Replies (2) \| Respond to of 4891

It has been clear to me for some time now (through patent searches and lots of digging elsewhere) that reticulose will get to market one day, but not from this company. Some with huge resources will accomplish what ADVR with very weak resources and management could not do. ADVR's future, if indeed it has one, lies with the derivatives of reticulose, but they better hurry are even that area will be lost to better managed, more resourceful, and much better financed drug companies that are already working on it. IMHO